ATE486866T1 - Verfahren zur herstellung von zolmitriptan - Google Patents

Verfahren zur herstellung von zolmitriptan

Info

Publication number
ATE486866T1
ATE486866T1 AT08715423T AT08715423T ATE486866T1 AT E486866 T1 ATE486866 T1 AT E486866T1 AT 08715423 T AT08715423 T AT 08715423T AT 08715423 T AT08715423 T AT 08715423T AT E486866 T1 ATE486866 T1 AT E486866T1
Authority
AT
Austria
Prior art keywords
zolmitriptan
producing
isolation
purification
optional
Prior art date
Application number
AT08715423T
Other languages
English (en)
Inventor
Michal Voslar
Monika Zatopkova
Hana Brusova
Lucie Krumbholcova
Original Assignee
Zentiva Ks
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zentiva Ks filed Critical Zentiva Ks
Application granted granted Critical
Publication of ATE486866T1 publication Critical patent/ATE486866T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/06Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
AT08715423T 2007-02-26 2008-02-25 Verfahren zur herstellung von zolmitriptan ATE486866T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CZ20070158A CZ2007158A3 (cs) 2007-02-26 2007-02-26 Zpusob prípravy zolmitriptanu
PCT/CZ2008/000022 WO2008104135A1 (en) 2007-02-26 2008-02-25 A method for the preparation of zolmitriptan

Publications (1)

Publication Number Publication Date
ATE486866T1 true ATE486866T1 (de) 2010-11-15

Family

ID=39639367

Family Applications (1)

Application Number Title Priority Date Filing Date
AT08715423T ATE486866T1 (de) 2007-02-26 2008-02-25 Verfahren zur herstellung von zolmitriptan

Country Status (10)

Country Link
US (1) US20100145064A1 (de)
EP (1) EP2118095B1 (de)
AT (1) ATE486866T1 (de)
CZ (1) CZ2007158A3 (de)
DE (1) DE602008003312D1 (de)
EA (1) EA017419B1 (de)
ES (1) ES2354590T3 (de)
PL (1) PL2118095T3 (de)
PT (1) PT2118095E (de)
WO (1) WO2008104135A1 (de)

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SI9111010B (sl) * 1990-06-07 2005-02-28 Astrazeneca Ab 3,5-disubstituirani indolni derivati kot "5-HT1-podobni" receptorski agonisti
GB9516145D0 (en) * 1995-08-07 1995-10-04 Wellcome Found Improved chemical synthesis
WO2005105792A1 (en) * 2004-04-22 2005-11-10 Dr. Reddy's Laboratories Ltd. Process for preparing optically pure zolmitriptan
EP1812428A2 (de) * 2004-11-19 2007-08-01 Teva Pharmaceutical Industries Ltd Zolmitriptan-kristallformen

Also Published As

Publication number Publication date
US20100145064A1 (en) 2010-06-10
EA200901151A1 (ru) 2010-02-26
DE602008003312D1 (de) 2010-12-16
WO2008104135A1 (en) 2008-09-04
CZ2007158A3 (cs) 2008-10-22
EP2118095B1 (de) 2010-11-03
PL2118095T3 (pl) 2011-04-29
PT2118095E (pt) 2011-01-11
EA017419B1 (ru) 2012-12-28
EP2118095A1 (de) 2009-11-18
ES2354590T3 (es) 2011-03-16

Similar Documents

Publication Publication Date Title
MX2010006799A (es) Benzofuropirimidinonas como inhibidores de la proteina cinasa.
CL2012001348A1 (es) Sal cristalina de hemitartrato del compuesto genz-112638, inhibidor de glucosilceramida sintetasa; composición farmacéutica que la comprende;y su uso en el tratamiento de la enfermedad de gaucher y enfermedad de fabry.
MX2009011579A (es) Pirimidinonas como moduladores de caseina cinasa ii (ck2).
EA200901563A1 (ru) Новый способ синтеза ивабрадина и его солей присоединения с фармацевтически приемлемой кислотой
WO2012042534A3 (en) Preparation of r-sitagliptin and intermediates thereof
IL183237A0 (en) Polymorphs of memantine hydrochloride
UY30082A1 (es) Forma cristalina de 1-(1-metiletil)-4`-((2-fluoro-4-metoxifenil)metil)-5`- metil-1h-pirazol-3`-o-b-d-glucopiranosido, un metodo para su preparacion y el uso de la misma para preparar medicamentos
EA201300423A1 (ru) Кристаллический конъюгат налоксол-peg
NO20083708L (no) 4-Fenyl-tiazol-5-karboksylsyre og 4-fenyl-tiazol-5-karboksylmider som PLK1-inhibitorer
MY158158A (en) Solid preparation
UA99787C2 (en) Lactams as beta secretase inhibitors
WO2009153461A3 (fr) Nouveau procede de synthese de la 7,8-dimethoxy-1,3-dihydro-2h-3- benzazepin-2-one, et application a la synthese de l'ivabradine et de ses sels d'addition a un acide pharmaceutiquement acceptable
EP2033960A3 (de) Kristalline Linezolidhydratform und Linezolidsalze
PH12012500992A1 (en) Compound, certain novel forms thereof, pharmaceutical compositions thereof and methods for preparation and use
EA201071120A1 (ru) Способ получения гетероарилбензопроизводных сульфаматов и кристаллической формы n-((2s)-6-хлор-2,3-дигидро-l,4-бензодиоксин-2-ил)метилсульфамида
ATE500226T1 (de) Aripiprazolhemifumarat und verfahren zu dessen herstellung
IL183163A0 (en) Sulfonamido-macrocycles as tie2 inhibitors and the salts thereof, a pharmaceutical composition comprising these compounds, the method of preparing and the use thereof
EA201200498A1 (ru) Новый способ синтеза ивабрадина и его фармацевтически приемлемых кислотно-аддитивных солей
EP2001856A4 (de) Kristalline formen von n-{2-tert.-butyl-1-[(4,4-difluorcyclohexyl)methyl]-1h-benzimidazol-5-yl}ethansulfonamidsalzen
EA201000611A1 (ru) 4,4-дизамещенные пиперидины
EA201000613A1 (ru) Тризамещенные пиперидины
ATE486866T1 (de) Verfahren zur herstellung von zolmitriptan
ATE512134T1 (de) Verfahren zur herstellung von 5-benzyloxy-2-(4- benzyloxyphenyl)-3-methyl-1h-indol
EA201000720A1 (ru) 4,4-дизамещённые пиперидины как ингибиторы ренина
DE602006014001D1 (de) Herstellung von 2-aminothiazol-5-carbonsäurederivaten

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties